Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a one-hour infusion every three weeks in patients with advanced cancer (Q33343738)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a one-hour infusion every three weeks in patients with advanced cancer |
scientific article |
Statements
1 reference
Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a one-hour infusion every three weeks in patients with advanced cancer (English)
1 reference
J Taïeb
1 reference
J H Beijnen
1 reference
W W ten Bokkel Huinink
1 reference
E Raymond
1 reference
J Wanders
1 reference
M Ravic
1 reference
P Fumoleau
1 reference
J P Armand
1 reference
J H M Schellens
1 reference
European Organization for the Research and Treatment of Cancer Early Clinical Study Group
1 reference
1 August 2002
1 reference
1 reference
20
1 reference
16
1 reference
3508-3521
1 reference
Identifiers
1 reference
1 reference